+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

The State of Personalized/ Precision Medicine

  • ID: 4858719
  • Report
  • October 2019
  • Region: Global
  • 119 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Adaptive Biotechnologies
  • Berg Health
  • Foundation Medicine
  • Loxo Oncology
  • Pfizer
  • Sanofi
  • MORE
The State of Personalized/ Precision Medicine

Summary

Personalized and precision medicines use information about a person's genes, proteins, and environment to prevent, diagnose, and treat disease. In cancer, personalized medicine uses specific information about an individual to help diagnose, plan treatment, find out how well treatment is working, or make a prognosis. This report covers current and future challenges for the development and launch of these medicines, focusing on challenges with transitioning these therapies from bench to bedside and demonstrating efficacy in order to secure reimbursement.

Scope
  • the publisher's The State of Personalized/Precision Medicine combines key opinion leader insight with in-house analyst expertise and research to provide an insight-rich look at personalized and precision medicine in the US, Europe, and Asia.
  • Components of the report include:
  • Definition of Personalized/Precision Medicine-Key attributes of personalized/precision medicine, examining and contrasting definitions by regulatory bodies and KOL respondents.
  • Personalized Medicine-Impact on Healthcare-Key factors to impacting healthcare for patients and stakeholders providing respondent mix by region and organization size.
  • Marketed products-Detailed information is provided for key personalized/precision medicines, including case studies for marketed oncology and rare disease therapeutics.
  • Pipeline products-The diverse Phase III pipeline is presented, including detailed information on key candidate's mechanism of action and clinical trial parameters.
  • Investment in Personalized Medicine-Investment in personalized medicine by indication and clinical trial design and approaches are presented, with case studies for three ongoing oncology trials being considered.
  • Market Opportunities and Challenges-Key areas of opportunity and roadblocks in developing, launching, and gaining reimbursement are analyzed by geography, company size, and seniority level.
  • Emerging Trends-Critical new trends, including the use of advanced digital technologies, are examined.
Reasons to buy
  • Develop business strategies by understanding the global trends shaping and driving the personalized/precision medicines market
  • Formulate effective sales and marketing strategies by understanding the competitive landscape of various competitors in a niche therapeutic space.
  • Identify areas of unmet need within the personalized/precision market to help drive research and development towards future market opportunities.
  • Gain insights to help plan and design your clinical trials.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
  • Identify key funding and partnership strategies.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Adaptive Biotechnologies
  • Berg Health
  • Foundation Medicine
  • Loxo Oncology
  • Pfizer
  • Sanofi
  • MORE
1. Preface
1.1 Table of Concents
1.2 Abbreviations
1.3 Related Reports
1.4 Upcoming Related Reports

2. Executive Summary

3. Overview of Personalized/Precision Medicine
3.1 Definition
3.2 Definition of Personalized/Precision Medicine
3.3 KOL and Payer Perspecive
3.4 Key Attributes of Personalized Medicine Therapy
3.5 Types of Biomarkers and Diagnostics

4. Impact of Personalized Medicine on Healthcare
4.1 Personalized Medicine - Impact on Healthcare - Patients
4.2 Advantages of Personalized Medicine - Patients
4.3 Role of Personalized Medicine in Clinical Unmet Needs
4.4 Personalized Medicine - Impact on Healthcare - Drug Developers' Perspective
4.5 Advantages of Personalized Medicine to Drug Developers
4.6 Personalized Medicine - Impact on Healthcare - Health System

5. Key Marketed Products

6. Pipeline Products

7. Investment in Personalized Medicine

8. Deal-Making Landscape

9. Market Opportunities and Challenges

10. Pricing, Reimbursement, and Regulatory Strategy

11. Personalized Medicine - Emerging Trends

12. Summary of Key Findings

13. Appendix
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Adaptive Biotechnologies
  • Ambry Genetics Corp
  • Astellas
  • AstraZeneca
  • Baxalta
  • BeiGene
  • Berg Health
  • BrainStorm Cell Therapeutics
  • Bristol-Myers Squibb
  • Catabasis
  • Clovis Oncology
  • Denovo Biopharma
  • Eli Lilly
  • Foundation Medicine
  • GenSight Biologics
  • IgDraSol
  • Ignyta
  • Kiadis
  • Konica Minolta
  • Loxo Oncology
  • Marinus
  • Merck & Co.
  • NantPharma
  • Nebula Genomics
  • Novartis
  • Pfizer
  • Precision Biosciences
  • Retrophin
  • Revolution Medicines
  • Rhythm Pharmaceuticals
  • Roche
  • Sanofi
  • Sarepta
  • Sutro Biopharma
  • Takeda
  • Vertex
  • Visterra
  • Voluntis
Note: Product cover images may vary from those shown
Adroll
adroll